PATH EX

PATH EX is a medical technology company focused on developing an innovative extracorporeal blood cleansing device. This device is designed to selectively remove pathogens, including multi-drug resistant bacteria, and endotoxins from the bloodstream. The primary aim is to provide immediate treatment for conditions such as bacteremia and sepsis, where rapid intervention is crucial.

The company operates in the healthcare and medical device market, targeting hospitals, clinics, and healthcare providers who treat patients with severe infections. PATH EX's business model revolves around the sale and distribution of its proprietary blood cleansing device, as well as potential recurring revenue from maintenance and consumables required for the device's operation.

Revenue is generated through direct sales to healthcare institutions, partnerships with medical distributors, and potential licensing agreements. The company's technology has been validated in preclinical studies, demonstrating a significant reduction in the concentration of bacteria in the bloodstream by over 95% in a single pass of contaminated blood.

Keywords: sepsis treatment, blood cleansing, medical device, pathogen removal, endotoxin reduction, healthcare innovation, bacteremia, multi-drug resistant bacteria, preclinical studies, rapid intervention.